Kamel Sadat

Kamel Sadat practices at Ascension Illinois - Imaging Chicago in Chicago, Illinois.

Kamel Sadat's NPI, 1013189281, was assigned on March 28, 2008. Kamel Sadat holds Indiana license 01079402A.

Kamel Sadat's primary practice is Ascension Illinois - Imaging Chicago, at 2900 N Lake Shore Dr, Chicago, IL 60657. The practice phone is (773) 665-3827.

Kamel Sadat's primary practice is Ascension Illinois - Imaging Chicago in Chicago, Illinois. Kamel Sadat is also affiliated with Northwestern Memorial Hospital. The medical group on file is Humboldt Park Health. Dmand AI also links Kamel Sadat to 4 more hospitals, 5 medical groups, 3 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kamel Sadat practices, 10 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Kamel Sadat's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Kamel Sadat's licenses on file in 4 states: Indiana, Alabama, Illinois and Texas.

CMS data shows 1,325 Medicare services from Kamel Sadat across 17 procedure codes in 2024, for 689 Medicare patients. Medicare paid $52,340 for them.

CMS counts 689 Medicare patients who saw Kamel Sadat in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kamel Sadat's median patient age at 69, with 54% women.

In 2024, Kamel Sadat wrote 1,612 Medicare Part D claims for 254 patients. 89% of them were for generic drugs. CMS names the drug for 1,439 of them, across 25 drugs with 11 or more claims each, at $213,055 in total drug cost. In 2023, CMS named 1,338 claims across 24 drugs.

Kamel Sadat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 278 general payments to Kamel Sadat from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Penumbra, Inc. paid the most, $3,637.